Digital Therapeutics Market Players:
- Omada Health, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ResMed
- Pear Therapeutics, Inc.
- Solera Network
- Akili Interactive Labs, Inc.
- Better Therapeutics, LLC
- Biofourmis
- Click Therapeutics, Inc.
- Naturalcycles Nordic AB
- BehaVR
Most of the companies are continuously collaborating, expanding, making agreements, and joining ventures for the growth of this sector and are estimated to be the major key players in this landscape.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of digital therapeutics is assessed at USD 10.44 billion.
The global digital therapeutics market size was valued at over USD 8.95 billion in 2025 and is expected to register a CAGR of more than 18.5%, exceeding USD 48.87 billion revenue by 2035.
North America digital therapeutics market will hold more than 40% share by 2035, driven by the surge in chronic illness and neurology devices, coupled with the geriatric population.
Key players in the market include ResMed, Pear Therapeutics, Inc., Solera Network, Akili Interactive Labs, Inc., Better Therapeutics, LLC, Biofourmis, Click Therapeutics, Inc., Naturalcycles Nordic AB, BehaVR.
